title: No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.
authors.affiliation: a Department of Haematology , Heraklion University Hospital, University of Crete , Crete , Greece ;
authors.forename: Christina
authors.initials: C
authors.lastname: Kalpadakis
authors.affiliation: b Department of Haematology , Athens Medical Center-Psychikon Branch , Athens , Greece ;
authors.forename: Gerassimos A
authors.initials: GA
authors.lastname: Pangalis
authors.affiliation: b Department of Haematology , Athens Medical Center-Psychikon Branch , Athens , Greece ;
authors.forename: Sotirios
authors.initials: S
authors.lastname: Sachanas
authors.affiliation: c Department of Anatomic Pathology , Evangelismos General Hospital , Athens , Greece ;
authors.forename: Demetra
authors.initials: D
authors.lastname: Rontogianni
authors.affiliation: d Department of Pathology , University of Athens , Athens , Greece ;
authors.forename: Penelope
authors.initials: P
authors.lastname: Korkolopoulou
authors.affiliation: d Department of Pathology , University of Athens , Athens , Greece ;
authors.forename: Vassilis
authors.initials: V
authors.lastname: Milionis
authors.affiliation: e Department of Haematology , National and Kapodistrian University of Athens, Laikon General Hospital , Athens , Greece.
authors.forename: Theodoros P
authors.initials: TP
authors.lastname: Vassilakopoulos
authors.affiliation: a Department of Haematology , Heraklion University Hospital, University of Crete , Crete , Greece ;
authors.forename: Helen A
authors.initials: HA
authors.lastname: Papadaki
authors.affiliation: e Department of Haematology , National and Kapodistrian University of Athens, Laikon General Hospital , Athens , Greece.
authors.forename: Maria K
authors.initials: MK
authors.lastname: Angelopoulou
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery*; D005260:Female; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab / Q000627:therapeutic use*; D013156:Splenectomy; D013160:Splenic Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D000069283:Rituximab